Wednesday September 11 2002
Cole Lecture Theatre
5th Floor
School of Medicine
85 Park Road
Auckland
A mix of short lectures and interactive small group discussion will cover the spectrum
of modern drug development science and its application to pharmaceutical medicine
in New Zealand.
|
Time
|
|
Topic
|
|
14.00 |
Dr David Woolner |
Introduction |
|
14.10 |
Small groups |
What do I need to know about drug development? What did I learn at the last workshop?
What is still unclear? |
|
14.30 |
Dr Michelle Glass |
Discovery: Transmembrane Receptor Signalling |
|
14.55 |
Small groups |
How does pharmacology help drug development? How does pharmacological science influence
drug development in humans? |
|
15.15 |
Everyone |
Afternoon tea |
|
15.30 |
Mr Simon Hurley |
Development: Individual doses – the Target Concentration Strategy |
|
15.55 |
Small groups |
What needs to be in the drug data sheet? What information is useful for dose individualization? |
|
16.15 |
Dr Richard Robson |
Drug Approval in New Zealand. What does MAAC do? |
|
16.40 |
Everyone |
Review of Small Group Outcome. What did we learn today? |
|
17.00 |
Meeting finishes |
|
This workshop has been organised as a joint activity of the Department of Pharmacology
& Clinical Pharmacology, University of Auckland and Merck, Sharpe & Dohme
(NZ) Ltd. Please contact one of us for registration details.
Nick Holford
David Woolner
